Why the study?
With the increasing incidence and prevalence of HF and CKD, a better understanding of the interface between both conditions was needed to optimize detection, prevention, diagnosis, and management.
Answers are grounded in this paper and cite their sources.
This KDIGO Controversies Conference report provides multidisciplinary consensus recommendations on the epidemiology, diagnosis, and management of HFrEF and HFpEF across the spectrum of chronic kidney disease, dialysis, and kidney transplantation.
The incidence and prevalence of heart failure (HF) and chronic kidney disease (CKD) are increasing, and as such a better understanding of the interface between both conditions is imperative for developing optimal strategies for their detection, prevention, diagnosis, and management. To this end, Kidney Disease: Improving Global Outcomes (KDIGO) convened an international, multidisciplinary Controversies Conference titled Heart Failure in CKD . Breakout group discussions included (i) HF with preserved ejection fraction (HFpEF) and nondialysis CKD, (ii) HF with reduced ejection fraction (HFrEF) and nondialysis CKD, (iii) HFpEF and dialysis-dependent CKD, (iv) HFrEF and dialysis-dependent CKD, and (v) HF in kidney transplant patients. The questions that formed the basis of discussions are available on the KDIGO website http://kdigo.org/conferences/heart-failure-in-ckd/, and the deliberations from the conference are summarized here.
No takes yet. Share an insight, caveat, or question.
House et al. (2019) conducted a review in Heart failure (HFpEF and HFrEF) and chronic kidney disease (nondialysis, dialysis-dependent, and kidney transplant). KDIGO consensus deliberations outline strategies for diagnosing and managing HFrEF and HFpEF across nondialysis CKD, dialysis-dependent CKD, and kidney transplant populations.
Synapse has enriched 10 related papers. Consider them for comparative context: